Ayr Wellness Inc (AYRWF)
2.219
+0.02
(+0.85%)
USD |
OTCM |
May 31, 16:00
Ayr Wellness Gross Profit Margin (Quarterly): 42.92% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 42.92% |
| December 31, 2023 | 43.00% |
| September 30, 2023 | 42.08% |
| June 30, 2023 | 48.53% |
| March 31, 2023 | 41.03% |
| December 31, 2022 | 46.39% |
| September 30, 2022 | 41.92% |
| June 30, 2022 | 36.44% |
| March 31, 2022 | 40.53% |
| December 31, 2021 | 45.84% |
| Date | Value |
|---|---|
| September 30, 2021 | 41.67% |
| June 30, 2021 | 24.45% |
| March 31, 2021 | 41.89% |
| December 31, 2020 | 57.63% |
| September 30, 2020 | 60.25% |
| June 30, 2020 | 60.54% |
| March 31, 2020 | 49.73% |
| December 31, 2019 | 25.67% |
| September 30, 2019 | 44.65% |
| June 30, 2019 | 34.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
24.45%
Minimum
Jun 2021
60.54%
Maximum
Jun 2020
43.46%
Average
42.50%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Flora Growth Corp | 21.37% |
| Tilray Brands Inc | 26.23% |
| Perspective Therapeutics Inc | -- |
| Palatin Technologies Inc | -- |
| Lumos Pharma Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.31% |
| Return on Assets | -12.42% |
| Return on Invested Capital | -17.80% |
| Profit Margin (Quarterly) | -89.86% |
| Operating Margin (Quarterly) | -0.54% |
| Return on Net Operating Assets | -12.97% |